Physician
Neurology
Dr. Richard J. Caselli, MD
|
|
Give Review
Doctor Richard J. Caselli, MD works in the field of Neurology. He attended Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a one of the best medicals schools. Columbia University College of Physicians & Surgeons is ranked 8/52 in Research/PrimaryCare. He received 2 awards: "Top MD" and "Super Doctor". Richard Caselli is a published doctor as well. He has 90 publications published. The latest was: APOE ε4 Genotype and the Risk for Subjective Cognitive Impairment in Elderly Persons. Richard Caselli accepts all Medicare patients.
Publications
- Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer Disease.
- Improved power to characterize longitudinal amyloid-β PET changes and evaluate amyloid-modifying treatments using a Cerebral white matter reference region.
- APOE ε4 Genotype and the Risk for Subjective Cognitive Impairment in Elderly Persons.
- A novel cortical thickness estimation method based on volumetric Laplace-Beltrami operator and heat kernel.
- Sex-Based Memory Advantages and Cognitive Aging: A Challenge to the Cognitive Reserve Construct?
- Physical activity level and future risk of mild cognitive impairment or Dementia: a critically appraised topic.
- Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.
- Assessing cognition and function in Alzheimer's Disease clinical trials: Do we have the right tools?
- Studying ventricular abNormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry.
- Public Perceptions of Presymptomatic Testing for Alzheimer Disease.
- Ataxin-2 as potential Disease modifier in C9ORF72 expansion carriers.
- Improving Service Quality in Primary Care.
- TMEM106B protects C9ORF72 expansion carriers against frontotemporal Dementia.
- Depressive symptoms in healthy apolipoprotein E ε4 carriers and noncarriers: a longitudinal study.
- Novel mutation in MAPT exon 13 (p.N410H) causes corticobasal degeneration.
- Does an Alzheimer's Disease susceptibility gene influence the cognitive effects of cancer therapy?
- Apolipoprotein E as a β-amyloid-independent factor in alzheimer's Disease.
- Ushering in the study and treatment of preclinical Alzheimer Disease.
- Profilin-1 mutations are rare in patients with amyotrophic lateral sclerosis and frontotemporal Dementia.
- Subjective cognitive decline: Self and informant comparisons.
- Higher serum glucose levels are associated with Cerebral hypometabolism in Alzheimer regions.
- Fibrillar amyloid correlates of preclinical cognitive decline.
- Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's Disease.
- Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively Normal, late-middle-aged persons at 3 levels of genetic r...
- Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder.
- The neuropsychology of normal aging and preclinical Alzheimer's Disease.
- Gray matter network associated with risk for Alzheimer's Disease in young to middle-aged adults.
- APOE and neuroenergetics: an emerging paradigm in Alzheimer's Disease.
- Longitudinal modeling of cognitive aging and the TOMM40 effect.
- Phenotypic differences between apolipoprotein E genetic subgroups: research and clinical implications.
- Characterizing the Preclinical Stages of Alzheimer's Disease and the Prospect of Presymptomatic Intervention.
- Correlations between FDG PET glucose uptake-MRI gray matter volume scores and apolipoprotein E ε4 gene dose in cognitively Normal adults: a cross-validation study usin...
- A roadmap for improving healthcare service quality.
- Blood pressure is associated with higher Brain amyloid burden and lower glucose metabolism in healthy late middle-age persons.
- Steroid-responsive encephalopathy subsequently associated with Alzheimer Disease pathology: A case series.
- Childhood-onset multiple sclerosis with progressive Dementia and pathological cortical demyelination.
- Autoimmune encephalopathy.
- Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic.
- Association between GAB2 haplotype and higher glucose metabolism in Alzheimer's Disease-affected brain regions in cognitively normal APOEε4 carriers.
- Anxiety Affects Cognition Differently in Healthy Apolipoprotein E {varepsilon}4 Homozygotes and Non-Carriers.
- APOE varepsilon2 and presymptomatic stage Alzheimer Disease: how much is not enough?
- Evidence for an association between KIBRA and late-onset Alzheimer's Disease.
- Hypometabolism in Alzheimer-affected Brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
- Neuronal gene expression in non-demented individuals with intermediate Alzheimer's Disease neuropathology.
- Whole genome association analysis shows that ACE is a risk factor for Alzheimer's Disease and fails to replicate most candidates from Meta-analysis.
- Higher serum total cholesterol levels in late middle age are associated with glucose hypometabolism in brain regions affected by Alzheimer's Disease and normal aging.
- Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
- Creativity: an organizational schema.
- Linking functional and structural Brain images with multivariate network analyses: a novel application of the partial least square method.
- Age-related memory decline and apolipoprotein E e4.
- Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.
- Efficacy of rivastigmine for cognitive symptoms in Parkinson Disease with dementia.
- Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's Disease.
- Development of methodology for conducting clinical trials in frontotemporal lobar degeneration.
- Compensation and finance in neurology.
- Correlating Cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment.
- Nonvasculitic autoimmune inflammatory meningoencephalitis as a cause of potentially reversible Dementia: report of 4 cases.
- Altered neuronal gene expression in brain regions differentially affected by Alzheimer's Disease: a reference data set.
- Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected Brain regions.
- Adjunctive haloperidol prophylaxis reduces postoperative delirium severity and duration in at-risk elderly patients.
- Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral Sclerosis.
- Statins differentially affect amyloid precursor protein metabolism in presymptomatic PS1 and non-PS1 subjects.
- Longitudinal tracking of FTLD: toward developing clinical trial methodology.
- Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
- GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers.
- Correlations between apolipoprotein E epsilon4 gene dose and whole Brain atrophy rates.
- January 16 highlight and commentary: subspecialization within somatosensory cortex.
- Identification of a novel risk locus for progressive supranuclear Palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms.
- "Idiopathic" rapid-eye-movement (REM) sleep behavior disorder is associated with future development of neurodegenerative Diseases.
- Gene expression profiles in anatomically and functionally distinct regions of the normal aged human Brain.
- Cognitive performance in older women relative to ApoE-epsilon4 genotype and aerobic fitness.
- Alzheimer's Disease a century later.
- Common Kibra alleles are associated with human memory performance.
- Cognitive frailty: Predementia Syndrome and vascular risk factors.
- A preliminary fluorodeoxyglucose positron emission tomography study in healthy adults reporting dream-enactment behavior.
- Increased tau burden in the cortices of progressive supranuclear Palsy presenting with corticobasal syndrome.
- Current epidemiology of mild cognitive impairment and other predementia Syndromes.
- Correlations between apolipoprotein E epsilon4 gene dose and Brain-imaging measurements of regional hypometabolism.
- Functional Brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.
- A distinctive interaction between chronic anxiety and problem solving in asymptomatic APOE e4 homozygotes.
- Apolipoprotein E epsilon 4 affects new learning in cognitively normal individuals at risk for Alzheimer's Disease.
- Current issues in the diagnosis and management of Dementia.
- Cognitive impairment, frontotemporal dementia, and the motor neuron Diseases.
- Small-amplitude cortical myoclonus in Parkinson's Disease: physiology and clinical observations.
- A distinctive interaction between memory and chronic daytime somnolence in asymptomatic APOE e4 homozygotes.
- Myoclonus in Lewy body Disorders.
- Apolipoprotein E and intellectual achievement.
- Association between an Alzheimer's Disease-Related Index and APOE ε4 Gene Dose.
- Medical management of frontotemporal Dementia.
Schools
Columbia University College Of Physicians and Surgeons
Mayo Clinic Rochester
University Iowa College Med
Procedures Preformed
- EEG (Electroencephalogram)
- EMG (Electromyography)
- Non-Cosmetic Chemodenervation
Conditions Treated
- Alzheimer's Disease
- Anterior Horn Disease
- Ataxia
- Autonomic Disorders
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Top MD
- Super Doctor
Education
-
Mayo School of Graduate Medical Education -
Columbia University College of Physicians & Surgeons
Hospital
-
Mayo Clinic - Phoenix/Scottsdale, Arizona
Drug Facts
| NPI NUMBER | 1568444255 | |
| NPPES Provider LastName | CASELLI | |
| NPPES Provider FirstName | RICHARD | |
| NPPES Provider ZIPCode | 852595404 | |
| NPPES Provider State | AZ | |
| Specialty Description | Neurology | |
| Total Claim Count | 303.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1568444255 |
| Last Name Of The Provider | CASELLI |
| First Name Of The Provider | RICHARD |
| View All |
Similar Doctors
|
|
Dr. Nida K. Laurin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles T. Crinnian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kenneth E. Root Jr., DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rashmi B. Halker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allan M. Block, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amaal J. Starling, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert D. Gunnink, DO |
|
|
Dr. Bryan K. Woodruff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Constantine G. Moschonas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kate W. Grimsrud, MD |
|
|
Dr. Heather B. Rigby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kristen K. Steenerson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy G. Schneider, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa M. Cortez, DO |